BAHIA SOFTWARE SL

Their core work

Bahia Software is a Spanish health-tech SME that builds software infrastructure for clinical AI applications, with a focus on medical imaging and oncology. Their core work involves developing data repositories that aggregate medical imaging data (MRI, CT scans) and ensuring those AI tools meet regulatory compliance requirements for clinical deployment. In the CHAIMELEON project they support the full pipeline from data ingestion to market-ready AI tools for detecting and managing lung, breast, colorectal, and prostate cancer. Their contribution to HUTER suggests additional capability in bioinformatics data management at the cellular level.

What they specialise in

How they've shifted over time

Both of Bahia Software's projects began in 2020, making a true chronological evolution hard to trace — this is a relatively young EU research participant with a very consistent profile from the start. The absence of keywords in the HUTER record and the rich keyword set in CHAIMELEON suggests that cancer imaging and AI tool compliance have become the dominant, better-documented focus. Their trajectory appears to be moving deeper into clinical AI productization — particularly the regulatory pathway required to bring AI diagnostics into actual hospital use — rather than broadening into new domains.

They are positioning themselves in the clinical AI compliance and imaging data infrastructure space — a high-growth niche as EU medical device regulations (MDR/IVDR) increasingly govern AI diagnostics.

How they like to work

Bahia Software operates exclusively as a consortium participant, never as coordinator, suggesting they are engaged as a specialist technical contributor rather than a project driver. With 23 distinct partners across 11 countries from just two projects, they are working in large, international consortia — both CHAIMELEON and HUTER are multi-partner research actions. This breadth of partners indicates comfort operating within complex, multi-national teams where they deliver a defined software or data-management component.

Despite only two projects, Bahia Software has built connections with 23 unique partners across 11 countries, which is a notably wide network for an SME at this stage. Their European reach spans well beyond Spain, reflecting the large consortium structure of the RIA projects they joined.

What sets them apart

Bahia Software occupies a specific and commercially relevant niche: they bridge the gap between research-grade AI imaging tools and the regulatory requirements that clinical deployment demands — a problem that stalls many academic cancer AI projects. As an SME, they bring agility and commercial focus to consortia that are otherwise dominated by hospitals and universities. For a consortium building a clinical AI product, they offer the software development and compliance know-how that academic partners typically lack.

Highlights from their portfolio

• CHAIMELEON
  A long-running (2020-2025) RIA focused on bringing AI cancer diagnostic tools to market, covering four cancer types and the full regulatory compliance pipeline — the clearest signal of Bahia Software's core business value.
• HUTER
  Participation in a human cell atlas project (2020-2022) with the largest single funding award (EUR 746,250), indicating data infrastructure capabilities beyond oncology imaging.